The global biotechnology & pharmaceutical services outsourcing market is foreseen to demonstrate notable expansion avenues during the assessment period of 2020 to 2030, highlights an upcoming research report by TMRR.
Biotech and pharma services outsourcing market to be worth over $91bn europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Biotechnology & Pharmaceutical Services Outsourcing Market Size Worth $91.4 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, Feb. 10, 2021 /PRNewswire/ The global biotechnology and pharmaceutical services outsourcing market size is expected
to reach USD 91.4 billion by 2028 registering a CAGR of 5.2%, according to a new report by Grand View Research, Inc. The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/biotech companies are facing challenges while performing in-house development, regulatory affairs, product maintenance, product design & development, product testing & validation, and training & education, such as lack of substantial expertise and expensive capability. This, in turn, has created lucrative opportunities for the growth of CMOs & CROs. Contract services are